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The objectives of this study were: 1) to evaluate the effects of a fructose enriched diet (FED) on rat sperm quality,
epididymal function (i.e. oxidative stress and alpha-glucosidase expression) and testosterone concentrations; 2) to
determine if the administration of ghrelin (Ghrl), reverses the effects induced by FED.
After validating the protocol as an inductor of metabolic syndrome like-symptoms, adult male rats were
assigned to one of the following treatments for 8 weeks: FED ¼ 10% fructose enriched in water (v/v); FED þ Ghrl
¼ fructose enriched diet plus Ghrl (6 nmol/animal/day, s.c.) from week 6–8; or C ¼ water without fructose (n ¼
5–10 animals/group).
FED significantly decreased sperm concentration and motile sperm count/ml vs C (FED: 19.0  1.6 
106sperm/ml and 834.6  137.0, respectively vs C: 25.8  2.8  106 and 1300.4  202.4, respectively; p < 0.05);
ghrelin injection reversed this negative effect (23.5  1.6  106sperm/ml and 1381.7  71.3 respectively). FED
resulted in hypogonadism, but Ghrl could not normalize testosterone concentrations (C: 1.4  0.1 ng/ml vs FED:
0.8  0.2 ng/ml and FED þ Ghrl: 0.6  0.2 ng/ml; p < 0.05). Ghrelin did not reverse metabolic abnormalities
secondary to FED. FED did not alter epididymal expression of antioxidants enzymes (superoxido-dismutase,
catalase and glutathione peroxidases –Gpx-). Nevertheless, FED þ Ghrl significantly increased the expression of
Gpx3 (FED þ Ghrl: 3.47  0.48 vs FED: 0.69  0.28 and C: 1.00  0.14; p < 0.05). The expression of neutral
alpha-glucosidase, which is a marker of epididymal function, did not differ between treatments.
In conclusion, the administration of Ghrl modulated the negative effects of FED on sperm quality, possibly by
an epididymal increase in Gpx3 expression. However, Ghrl could not neither normalize the metabolism of FED
animals, nor reverse hypogonadism.1. Introduction
Metabolic syndrome (MetS) is a cluster of abnormalities that includes
overweight, dyslipemia and impaired glucose metabolism, with insulin
resistance and central obesity recognized as causative factors [1, 2].
Dysregulated production of adipokines, chronic low-grade inflammation
and oxidative stress are being hypothetized as the cellular/molecular
bases of the metabolic abnormalities and the comorbidities associated
with this pathology [reviewed in 1, 2].. Martini).
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human physiology, including reproductive potential. In humans, MetS
has been associated with hypogonadism [1, 3, 4]; in fact, some authors
suggested that this trait should be added to the group of abnormalities
that characterizes MetS [5]. Moreover, although without consensus [3,
6], some studies have reported a decrease in human seminal quality
secondary to this pathology [4, 7, 8, 9, 10]. Specifically, some studies
proposed that the oxidative stress associated to MetS and related diseases
(such as obesity and type 2-diabetes) results in sperm membrane lipidNovember 2019
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decrease and DNA damage [reviewed in 1, 7].
Ghrelin (Ghrl) is a 28 aminoacide peptide originally described by its
growth hormone stimulatory ability and its orexigenic effects [11].
Nonetheless, Ghrl has emerged as an important metabolic regulatory
substance, related to glucose and lipids metabolism [12, 13]. Further-
more, Ghrl has been linked with mammals reproductive capability [14].
Particularly in males, it is known that hyperghrelinemia inhibits LH and
testosterone (T) secretion and might reduce spermatogenesis, contrib-
uting to the suppression of male reproductive axis in situations of
negative energy balance. Conversely, testicular Ghrl is regulated by LH
secretion and GHSR-1a, the active Ghrl receptor, is expressed in rodent
Leydig cells, Sertoli cells and even in germ cells. In addition, Ghrl has
been shown to control the secretion of stem cell factor, suggesting that
Ghrl might paracrinally regulate spermatogenesis [reviewed in 14].
It has been reported that obese patients and/or those with MetS,
exhibit decreased circulating levels of Ghrl and, that progressive lower
Ghrl is associated with increasing MetS severity [3, 6, 9, 15, 16, 17].
Because of its anti-inflammatory and anti-oxidant properties, Ghrl has
been suggested as a positive prognostic factor in MetS [18, 19, 20, 21].
Interestingly, Catak et al. (2014) reported in a male rat MetS model that,
although ghrelinemia did not vary in comparison to control animals,
testicular and seminal vesicle Ghrl levels were significantly decreased
[22]. In another research study developed in rabbits, Marchiani et al.
(2015) demonstrated that MetS, induced by a high fatty diet for 12
weeks, reduced sperm motility, normal morphology and the capability of
the acrosome to react to progesterone. Moreover, these authors proposed
that the structures affected by MetS were the testis and, notably,
epididymis, since the expression of some inflammatory genes was
increased in these tissues [23]. Likewise in humans, we have previously
linked obesity (closely related to MetS) with epididymal dysfunction [24,
25]. However, despite the essential role of epididymis in sperm function
and fertilizing capability, the possible deleterious effects of MetS (or
related pathologies) on this tissue have rarely been studied. Moreover,
since epididymal maturation requires a fine tuned balance between
reactive oxygen species (ROS) production and neutralization, systemic or
local alterations in the redox state may negatively impact semen quality
[7, 26]. It is important to remark that several sperm parameters may be
altered by epididymal dysfunction, including motility, sperm count and
even morphology [23, 27, 28].
Therefore, the objectives of this study were to evaluate: a) the effects
of a fructose enriched diet (FED: 10% fructose v/v), commonly used as a
MetS model, on rat sperm quality and plasma T concentrations; b) if the
detrimental effects of the FED on sperm quality are associated with an
increase in epididymal oxidative stress or an alteration in neutral alpha-
glucosidase expression (enzyme involved in epididymal maturation that
is experimentally and clinically used as an epididymal functional marker
[28, 29]) and, c) if Ghrl administration may prevent/reverse the possible
negative effects induced by the FED.
2. Material and methods
2.1. Animals
Experiments were conducted in accordance with the Guide for the
Care and Use of Laboratory Animals from the Medicine School of the
Cordoba National University (UNC-RHCS 674/09). This animal ethics
committee approved the protocol used in this study (Ref. 73/18; October
25, 2018). The study complies with the ARRIVE guidelines.
We used adult (70–90 days) male inbreedWistar rats maintained on a
12:12 h light:dark basis at 22  2 C with water and food (Grupo Pilar-
Gepsa, Cordoba, Argentina) provision ad libitum.
2.2. Protocol validation (5 weeks of treatment)
An initial group of male rats were randomly assigned to one of the2
following treatments, in order to validate our experimental protocol as an
inductor of MetS-related symptoms:
- FED ¼ fructose enriched diet: free access to food and water with 10%
fructose (v/v), for 5 weeks.
- C ¼ control: free access to food and water, for 5 weeks.
It is important to remark that this is a commonly used protocol
inductor of MetS, applied in general for 4–6 weeks [30, 31].
Body weight was evaluated before treatment, during (once a week)
and at the end of the experimental period. Other morphometric param-
eters evaluated were: waist circumference, weight of visceral fat, weight
of epididymal fat and total abdominal fat weight. Metabolic profile was
evaluated by the quantification of: plasma glucose, cholesterol, high-
density lipoproteins (HDL), low-density lipoproteins (LDL) and
triglycerides.2.3. Experimental groups (8 weeks of treatment)
After validation of the protocol, a new group of male rats were
randomly assigned to one of the following experimental groups:
- FED ¼ fructose enriched diet: (v/v), for 8 weeks.
- FED þ Ghrl ¼ fructose enriched diet plus ghrelin: a subgroup of FED
animals, from week 6–8, were also injected s.c. with 6 nmol/animal/
day of Ghrl.
- C ¼ control: free access to food and water, for 8 weeks.
Treatments were applied for 8 weeks, in order to assure that the
evaluated spermatozoa were formed and matured under the effects of the
diet (i.e. to cover the whole spermatogenic cycle and epididymal transit).
Ghrelin was dissolved in isotonic solution and administered by subcu-
taneous injections twice a day (with 3 nmol/animal in each injection, at 9
a.m. and 5 p.m.), for the last two weeks of treatment. Control and FED
animals received the vehicle in the same regimen. The doses of Ghrl
employed in this study have been previously used by several authors [32,
33].
As for protocol validation, morphometric and metabolic parameters
were quantified. Sperm functional activity, plasma T and epididymal
expression of antioxidants enzymes and neutral alpha-glucosidase (Ganc)
were also assayed.2.4. Plasma metabolic profile
After 12 h fasting, rats were anesthetized by isofluorane and blood
collected from abdominal aorta. Serum glucose, cholesterol, tri-
glycerides, HDL and LDL were evaluated with kits from GT Laboratories
(Rosario, Argentine).2.5. Sperm functional activity
After euthanasia, caudal epididymal spermatozoa were obtained and
incubated for 15 min in 5 ml of modified Tyrode's medium at 37 C (with
95% air: 5% CO2) [34]. After incubation, sperm concentration and
motility were quantified in a Makler counting chamber (Sefi-Medical
Instruments, Israel) [35]. Motility was expressed as percentage of motile
cells (progressive plus non-progressive gametes). Sperm viability was
assessed using the supravital stain Hoechst 33258 as previously
described [36] and evaluated with epifluorescence microscope. The
percentage of immature gametes was evaluated, quantifying the per-
centage of spermatozoa showing a persistent cytoplasmic drop [29].
Acrosomal reaction was assayed by the coomassie blue technique [37]
and the results were expressed as percentage of spermatozoa with intact
acrosome.
Table 2
Morphometric and metabolic parameters of male rats treated for 5 weeks with a
fructose enriched diet (FED).
Paremeters C (n ¼ 5) FED (n ¼ 5)
Body weight (g) 352.5  8.8 409.8  9.8
Body weight gain (g) 30.0  4.1 32.5  4.4
Waist circumference (cm) 16.6  1.5 19.5  1.4
Visceral fat (g) 4.8  0.4 a 9.4  1.3 a
Epididymal fat (g) 5.4  0.4 7.2  1.0
Total abdominal fat (g) 10.2  0.7 b 16.6  2.1 b
Plasma glucose (mg/dl) 92.4  3.5 85.2  3.8
Cholesterol (mg/dl) 49.0  2.4 c 63.2  3.3 c
HDL (mg/dl) 24.4  1.4 22.4  0.9
LDL (mg/dl) 12.2  1.9 d 22.2  3.1 d
Triglycerides (mg/dl) 62.2  7.3 e 92.8  9.8 e
FED animals had free access to food and water enriched with fructose (10%
fructose v/v) for 5 weeks. Control animals (C) received water without fructose for
the same period. Body weight gain ¼ final body weight – initial body weight.
HDL ¼ high-density lipoproteins. LDL ¼ low-density lipoproteins. Identical let-
ters indicate significant differences (p < 0.05).
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T concentration was determined by an in-house enzyme immuno-
assay using a polyclonal anti-T antibody, T standard and their corre-
sponding horseradish peroxidase conjugate (T R156/7, Department of
Population Health and Reproduction, C. Munro, UC Davis, CA, USA). The
assay sensitivity was 0.047 ng/ml. Intra-assay and inter-assay coefficient
of variation were less than 10% and 15%, respectively.
2.7. Antioxidants enzymes and Ganc epididymal expression
After euthanasia, the proximal portion of the epididymis was
sampled, snap frozen in liquid nitrogen and conserved at -80 C until
mRNA extraction. Messenger RNA was extracted using Trizol reagent
(Thermo Scientific) according manufacturer protocol, its concentration
determined with Nanodrop, and stored at -80 C until cDNA conversion.
An aliquot of the extracted RNA was converted to cDNA using M-MLV
Reverse Transcriptase (Promega), following the manufacturer protocol,
and stored at -20 C until its use.
The mRNA expressions of Ganc, catalase (Cat), glutathione peroxi-
dase 3 and 5 (Gpx3 and Gpx5), superoxide dismutase 1 (Sod1) and Actb
(β-actin), as housekeeping gene, were measured by qRT-PCR, using
primers (Invitrogen) and SYBR Green PCR Master Mix (Applied Bio-
systems). Primers were designed with Primer Express software (Applied
Biosystems) from the corresponding Rattus novergicus mRNA. Table 1
reports primers sequences and accession numbers.
All samples were run in triplicate for each gene and for β-actin. There
were no differences in β-actin expression among the groups. The change
in threshold cycle (ΔCt) between the mean Ct for each gene and the mean
Ct for β-actin mRNA from the same animal were used to calculate the
relative mRNA expression for each gene. The effect of FED (at 5 and 8
weeks) and FED þ Ghrl on each gene was analyzed by ANOVA using the
ΔCt values. Data are shown as the mean fold change in expression in the
FED (5 and 8 weeks) and FED þ Ghrl groups relative to the C group; fold
change in each sample was calculated as 2-ΔΔCt, where ΔΔCt is the
difference between ΔCt in each sample and the mean ΔCt in the C group.
2.8. Statistical analysis
Results were expressed as Mean  SEM and were analyzed by one-
way ANOVA with LSD Fisher as post-hoc comparison analysis. In all
cases, p values under 0.05 were considered of statistical significance.
Statistical analyses were performed with Infostat 2016p (Group Infostat,
Facultad de Ciencias Agropecuarias – Universidad Nacional de Cordoba,
Argentina).
3. Results
Morphometric and metabolic results from male rats treated with the
FED or C protocol for 5 weeks are shown in Table 2. As can be seen, FED
increased all the morphometric parameters evaluated (particularly
epididymal fat, that increased 33% compared to C), although only
visceral fat and total abdominal fat reached statistical significance,
increasing in 96% and 63% respectively compared to C. In addition, FED
significantly increased the plasma concentrations of cholesterol (in 27%),
LDL (in 82%) and triglycerides (in 49%). Glucemia and HDLTable 1









concentration did not differ between groups.
Once validated the protocol, treatments were applied for 8 weeks in
order to cover spermatogenesis and epididymal transit (Fig. 1 and Ta-
bles 3, 4, and 5). Fig. 1 shows body weight evolution of male rats from
groups FED, FED þ Ghrl and C. No significant differences were observed
in this parameter between groups. An increase in body weight indepen-
dent of treatment was observed in male rats (days 1 vs 7 vs 14 vs 21 and
28 vs 35 vs 42, 49 and 56; p < 0.05). Food intake of FED þ Ghrl animals
was similar than that of FED or C males (results not shown).
As depicted in Table 3, FED significantly increased cholesterol and
triglycerides concentrations. The injection of Ghrl did not reverse dysli-
pidemia. Nevertheless, Ghrl administration significantly increased HDL
concentrations when compared to C.
Regarding the reproductive parameters (Table 4), FED significantly
reduced sperm concentration and motile sperm count/ml compared to C.
This reduction in motile sperm count was prevented/reversed by the
injection of Ghrl during the last two weeks. Furthermore, FED animals
were hypogonadic, evidenced by lower T levels in comparison to C.
Decreased plasma T levels were also detected in FED þ Ghrl (vs C).
Table 5 shows the relative expression of antioxidants enzymes (Sod1,
Cat, Gpx3 and Gpx5) and Ganc in the epididymis of C, FED (for 5 and 8
weeks) and FEDþGhrl groups. FEDmodified, neither at 5 nor at 8 weeks,
the expression of antioxidants enzymes or that of neutral alpha-
glucosidase. The co-administration of Ghrl to the FED animals from
weeks 6–8, significantly increased the expression of GPx3 compared to
FED and C.
4. Discussion
The objectives of this study were to evaluate in male rats, if a FED that
provokes MetS-related symptoms, exerts deleterious effects on plasma T
and semen quality and if the co-administration of Ghrl reverse/prevent
these effects. We aimed to evaluate also, if these deleterious effects are
associated with increased oxidative stress in epididymis (structure
involved in sperm maturation) and if Ghrl may ameliorate the oxidative




















Fig. 1. Body weight evolution of male rats treated for 8 weeks with a fructose enriched diet (FED; 10% fructose v/v in drinking water). A subgroup of FED animals
received ghrelin (s.c., 6 nmol/animal/day) for the last two weeks of treatment (FED þ Ghrl, i.e. from day 42–56). FED and C (control animals) were injected s.c.,
during this last two weeks of treatment, with isotonic solution (ghrelin vehicle).Values are expressed as MeanSDM. Number of animals/treatment: C ¼ 7; FED ¼ 10;
FED þ Ghrl ¼ 5. An increase in food intake independently of treatment was seen in male rats: days 1 vs 7 vs 14 vs 21 and 28 vs 35 vs 42, 49 and 56 (p < 0.05).
Table 3
Morphometric and metabolic parameters of male rats treated for 8 weeks with a
fructose enriched diet (FED), with or without the administration of ghrelin for
the last two weeks of treatment.
Paremeters C (n ¼ 9) FED (n ¼ 10) FED þ Ghrl (n ¼ 5)
Body weight (g) 367.9  16.2 384.7  8.5 403.6  10.0
Body weight gain (g) 125.3  9.0 132.9  9.4 114.2  20.7
Waist circumference (cm) 16.7  1.6 15.8  0.7 17.2  0.4
Visceral fat (g) 8.1  0.9 11.1  1.2 10.5  1.4
Plasma glucose (mg/dl) 97.4  2.7 98.6  4.0 92.8  5.3
Cholesterol (mg/dl) 54.8  3.0 a-b 72.8  4.7 a 76.6  7.2 b
HDL (mg/dl) 22.3  1.7 c 28.8  2.1 30.8  3.9 c
LDL (mg/dl) 20.0  3.4 26.4  4.5 28.6  4.7
Triglycerides (mg/dl) 63.2  5.3 d-e 88.2  9.6 d 86.2  7.1 e
FED þ Ghrl animals had free access to food and water enriched with fructose
(10% fructose v/v) for 8 weeks and, from week 6 onward, received a daily
subcutaneous injection of ghrelin (6 nmol/animal/day). FED animals had free
access to food and water enriched with fructose (10% fructose v/v) for 8 weeks.
Control animals (C) received water without fructose for the same period. These
two groups were injected, during the last two weeks of treatment, with isotonic
solution (ghrelin vehicle). Body weight gain ¼ final body weight – initial body
weight. HDL ¼ high-density lipoproteins. LDL ¼ low-density lipoproteins.
Identical letters indicate significant differences (p < 0.05).
Table 4
Epididymal sperm functional activity and plasma testosterone of male rats
treated for 8 weeks with a fructose enriched diet (FED), with or without the
administration of ghrelin for the last two weeks of treatment.
Parameter C (n ¼ 9) FED (n ¼ 10) FED þ Ghrl (n ¼
5)
Testicular weight (g) 2.9  0.1 3.0  0.1 2.9  0.1
Concentration (x106/
ml)
25.8  2.8 a 19.0  1.6 a 23.5  1.6
Motility (%) 50.9  4.8 48.9  5.3 59.2  2.5




1381.7  71.3 c
Cytoplasmic drop (%) 0.1  0.1 0.4  0.2 0.0  0.0
Viability (%) 89.4  3.0 88.7  1.2 89.2  2.1
Acrosomal reaction
(%)
92.7  1.9 91.5  1.9 90.0  2.2
Testosterone (ng/ml) 1.4  0.1 d-e 0.8  0.2 d 0.6  0.2 e
FED þ Ghrl animals had free access to food and water enriched with fructose
(10% fructose v/v) for 8 weeks and, from week 6 onward, received a daily
subcutaneous injection of ghrelin (6 nmol/animal/day). FED animals had free
access to food and water enriched with fructose (10% fructose v/v) for 8 weeks.
Control animals (C) received water without fructose for the same period. These
two groups were injected, during the last two weeks of treatment, with isotonic
solution (ghrelin vehicle). Motile sperm count/ml ¼ concentration x motility.
Identical letters indicate significant differences (p < 0.05).
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symptoms, we applied the diet for 8 weeks in order to cover spermato-
genesis and epididymal transit. We found that FED significantly
decreased sperm concentration, while Ghrl co-administration increased
this parameter to values comparable to C (although not reaching statis-
tical significance vs FED group). Because of the ability of Ghrl of
reversing/preventing the decrease in sperm concentration, the motile
sperm count/ml increased significantly in FED þ Ghrl vs FED. Although
this variable is the product of other two (concentration and motility), we
consider it has an important biological meaning. In order to fertilize an
egg, it is necessary for the sperm to move.
It would be necessary to determine in our experimental conditions,
which mechanisms are implicated in sperm concentration reduction;
which is actually the most important variable of sperm quality that
changed in our study. Classically, a decrease in sperm concentration has
been attributed to alterations in spermatogenesis [38]. Nevertheless,
Marchiani et al (2015) andMallidis et al (2011) described, in rabbits with
MetS, a decrease in sperm quality without detecting histological alter-
ations in the testis [23, 39]. Besides, since Ghrl was administered only4
during the last two weeks of treatment, its effects would only cover the
last part of spermatogenesis and all the epididymal transit. So, it is
feasible that the beneficial effects of Ghrl are associated to epididymal
physiology; for example increasing sperm survival and/or concentrating
gametes [28]. Concordantly, Marchiani et al. (2015) found in a rabbit
MetS model, an altered epididymal expression of Aqp1 (aquaporin 1),
and suggested that this may underlie defective fluid resorption in the
organ [23].
Although not all [3, 6, 39], several other authors found alterations in
sperm quality secondary to MetS or MetS-related diets [4, 7, 8, 9, 10, 23,
40]. The sperm variables most affected are sperm concentration and
motility. Ferramosca et al. (2017), fed male rats with a high-fat diet
(enriched with 35% of fat and 15% sucrose) during 4 weeks, and found a
significant decrease (of more than 40%) in sperm concentration and in
motility; the authors attributedmotility reduction to an increase in sperm
oxidative stress [40]. This oxidative stress might affect, for example,
epididymal sperm survival.
Table 5
Expression of antioxidants enzymes and neutral alpha-glucosidase in epididymis of male rats treated for 5 or 8 weeks with a fructose enriched diet (FED), with or without
ghrelin administration from week 6–8 inclusive.
Parameter C (n ¼ 11) FED 5 weeks (n ¼ 6) FED 8 weeks (n ¼ 5) FED þ Ghrl (n ¼ 5)
Superoxido dismutase (Sod1) 1.00  0.16 0.89  0.18 0.82  0.42 0.68  0.16
Catalase (Cat) 1.00  0.12 0.86  0.15 0.96  0.19 1.57  0.54
Glutation peroxidase 3 (Gpx3) 1.00  0.14 a 0.76  0.11 0.69  0.28 b 3.47  0.48 a-b
Glutation peroxidase 5 (Gpx5) 1.00  0.24 0.60  0.08 0.98  0.30 1.31  0.16
Neutral alpha-glucosidase (Ganc) 1.00  0.10 0.84  0.10 1.36  0.27 1.09  0.62
Epididymal enzymes expression of each gene was quantified by qRT-PCR. Data are shown as the mean fold change in expression (SEM) in the FED (5 and 8 weeks) and
FED þ Ghrl groups relative to the control group.
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susceptible to oxidative damage for three major reasons: first, post-
testicular spermatozoa are silent cells, with a compacted DNA, which
are not able to participate in any transcriptional activation when chal-
lenged by oxidative stress. Second, spermatozoa are also silent in terms of
protein synthesis, because of the loss of most of their cytoplasm and sub-
cellular organelles. Third, spermatozoa are highly reactive to oxidative
injury because their membranes have high concentrations of PUFAs,
lipids prone to oxidation [26]. Furthermore, since sperm maturation
processes and specifically, epididymal maturation, require the action of
H2O2 for sperm proteins sulfoxidation, oxidative-antioxidative balance
must be strictly controlled [26]. For this reason, mammalian epididymis
expresses, among other antioxidants, several glutathione peroxidases
(Gpxs). To date, is the organ in which one can find expressed, in different
levels and sub-territories, most of the known Gpxs (from Gpx1 to Gpx8)
[41,42]. Gpx3 and Gpx5 are quantitatively the most abundant Gpxs,
representing more than 95% of the epididymal Gpxs [26]. Besides, Gpx5
is specific from this tissue [26, 41].
In our experimental conditions, the expression of the epididymal
antioxidant enzymes Cat, Sod1, Gpx3 and Gpx5, did not differ by FED (at
week 5 or 8).These results seem to indicate that FED did not increase
oxidative stress at epididymal level. Regretfully, we did not evaluate
enzymes content and/or activity, in order to reassure this assumption. In
any way, the co-administration of Ghrl significantly increased Gpx3
expression, even in comparison with the C group. It is important to
remark that Gpxs mediate, as Cat, the recycling of H2O2 to water.
Nevertheless, Cat is activated when H2O2 concentrations are far above
physiological levels, being an acute stress-response scavenger. None-
theless, Gpxs deal with small physiological adjustments of H2O2 con-
centrations, and are more versatile than Cat in the substrates they can
metabolize. Gpxs can recycle organic peroxidized molecules, including
those in free PUFAs and in complex membranes, acting therefore not only
as scavenger but also, as repairing enzymes [reviewed in 26]. Further
studies are necessary in order to elucidate if the increase in epididymal
Gpx3, induced by Ghrl, functions as a “protective” mechanism naturally
provoked by this substance; and/or an amplified reaction by Ghrl to some
degree of systemic/local oxidative stress not evidenced by the other
antioxidant enzymes and/or the detection methods used in this study.
There are few studies investigating the effects of Ghrl on Gpxs activity
and/or expression; none of them in epididymis. Nevertheless, the ma-
jority of these studies have detected an antioxidant effect of Ghrl which is
even more potent than in basal conditions. That means that Ghrl signif-
icantly increases Sod, Cat and/or Gpxs expression and/or activity,
compared to control groups [32, 43, 44, 45, 46]. Asadi et al (2018),
demonstrated that Ghrl administration to rats with varicocele signifi-
cantly increased Sod and Gpxs testicular levels and reduced malondial-
dehyde, not only vs varicocele rats but also vs control ones. These authors
informed an improvement in sperm count and viability in Ghrl injected
rats vs those with varicocele [43]. Similar results were observed in
another study in rats, in which testicular toxicity was induced by cad-
mium [46]. Furthermore in humans, failure in spermatozoa Gpxs
expression has been correlated with infertility [47, 48]. Finally, studies
conducted in knockout models for Gpxs have demonstrated that Gpxs5
play important roles in mammalian sperm physiology [reviewed in 26].
Therefore, it might be possible in our study that the reversion in sperm
abnormalities caused by Ghrl would be attributable to this increase in
Gpx3 expression.
Additionally to sperm quality, FED significantly reduced plasma T
concentrations. This feature has been found by several authors, not only
in animal models but also in humans [3, 4, 23, 39]. Nonetheless, some
authors actually found an increase in this androgen in MetS models [22].
Hypogonadism in MetS and MetS-related models has been attributed to
an increase in T aromatization to estradiol, which occurs in adipose tissue
[reviewed in 49]. This may explain why Ghrl co-administration did not
prevent/reverse T decrease, since morphometric parameters were similar
in FED and FED þ Ghrl groups.
Although epididymal function and specifically Ganc expression is T-
dependent [27], we did not find any alteration in the expression of this
enzyme. Since epididymal intraluminal T levels are much higher than
plasma concentrations [50, 51], it is possible that plasma androgen levels
are not as important for epididymal function as local androgen
concentrations.
Regarding metabolism and in concordance with previous publica-
tions [22, 30], FED provoked MetS-related abnormalities. Specifically,
after 5 weeks of treatment, FED significantly increased visceral and total
abdominal fat, and resulted in dyslipidemia (by enhancing total choles-
terol, LDL and triglycerides levels). The effects of FED at 8 weeks were
not as noticeable as that at 5 weeks, since only cholesterol and tri-
glycerides levels varied significantly. It seems that male rats achieved
some kind of “compensation”. This compensation should not be attrib-
uted to a reduction in food intake, since this parameter was similar in the
three experimental groups. Although it might be related to a decreased in
fructose enriched water intake, this parameter was not measured. In any
case, the administration of Ghrl did not reverse dyslipidemia. Never-
theless, Ghrl significantly increased HDL levels, which is a good prog-
nostic lipoprotein for cardiovascular risk [52]. Besides, it has been
reported that during fasting, Ghrl interacts with a species of HDL asso-
ciated with clusterin, paraoxonase and apolipoprotein A-I, linking hunger
with growth hormone release [53]. An increase in plasma Ghrl due to the
exogenous administration of the peptide, might rise the levels of this
particular HDL.
In summary, the application of a FED to male rats for 8 weeks
significantly decreased sperm concentration and plasma T levels. The co-
administration of Ghrl during the last two weeks of treatment prevented/
reversed sperm quality impairment, without reversing hypogonadism. It
is possible that an epididymal increase in the expression of Gpx3 might
be responsible, at least in part, for sperm quality recovery.
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